From an immunological point of view, pregnancy is a unique set of circumstances because a woman’s body has to ‘withstand something that is foreign to it’. The mother has to carry the embryo and, in order to do so, her immune system needs to accept co-existence with cells that are at least half foreign in origin. Using a […]
Recurrent Pregnancy Loss
We are not yet fully aware of the exact reasons why sometimes a pregnancy happens and sometimes it does not. The embryo implantation process is an entire set of processes, many of which are unknown.
Based on the fact that the main factors that have an impact on implantation are the embryo and the female uterus, huge progress has been made […]
After ovulation, follicles transform into the corpus luteum or ‘yellow body’. Corpus luteum development depends on the luteinising hormone (LH) surge before ovulation and on the number of receptors for this gonadotropin in the granulosa cells and in the theca cells. Both types of cells go through significant changes in structure and composition and this turns the walls of the corpus […]
Egg donation has become an option for women who, for whatever reason, can no longer use their own ova. For example, due to poor ovarian reserve, poor oocyte quality and premature menopause.
The process is widely used in Spain. As well as exceeding organ
donations and transplants in number, we also have the largest number of egg
donors in Europe.
Whilst it is not part of the day-to-day routine at reproductive
medicine clinics, it is now increasingly common to have to transport biological
samples (oocytes, semen or embryos) from one clinic to another and even from
one country to another.
There can be several reasons for this such as the following:
couple wishes to continue their treatment in a […]
Pre-implantation genetic diagnosis(PGD) consists of studying chromosomalabnormalities and genetic abnormalities in the embryo prior to transfer to the mother. Itspurpose is to ensure that children are healthy and to bring thetransmission of a given condition to an end.
Significant progress that has revolutionised this area ofreproductive medicine has been made over the last few years and specificallywith regards to one type […]
The extent of the issue
Obesity is a public health issue both in the general population and in women of childbearing age. The figures are a proof of this and, far from improving, the problem has been getting progressively worse over the last few years.
Maternal obesity in the United States of America was calculated to be 7% in 1980 and had risen up to 24% by 1999. If we take into account both obesity and excess weight, the available data indicates that the figures were 37.1% in 1999 and 40.5% in 2003.
The NHANES (National Health and Nutrition Examination Survey) reveals obesity figures (BMI or body mass index ≥ 30 kg/m2) in women of reproductive age (20 to 39 years of age) of 31.9%.
In other words, one in every three women of a fertile age is obese. […]
Obesity, when understood as a body mass index (BMI) in excess of 30kg/m2, is associated with numerous health issues including hypertension, diabetes, hypercholesterolemia and so on. It also affects fertility. In women, the impact of obesity is very clear. It generates hormonal abnormalities that have a direct impact on a woman’s ability to reproduce. As a result, obesity in women has been the subject of numerous studies and there are a large number of publications on the matter. […]
A patient can be classified as having poor response when the number of oocytes obtained during a cycle of in vitro fertilisation is under what was expected. The criteria generally used to label a patient as a poor responder is when 3 or fewer oocytes are retrieved and she has incredibly low ovarian reserve markers (fundamentally, AMH and AFC). […]
If you have been trying to get pregnant for a year or more without success, it’s time to search for an expert’s advice. […]